Neurofibromatosis 2
Publisher
Springer New York
Reference25 articles.
1. Asthagiri, A. R., Parry, D. M., Butman, J. A., et al. (2009). Neurofibromatosis type 2 (Seminar). Lancet, 373, 1974–1986. 2. Barbi, G., Rossier, E., Vossbeck, S., et al. (2002). Constitutional de novo interstitial deletion of 8 Mb on chromosome 22q12.1-12.3 encompassing the neurofibromatosis type 2 (NF2) locus in a dysmorphic girl with severe malformations. Journal of Medical Genetics, 39, E6. 3. Baser, M. E., Friedman, J. M., Aeschliman, D., et al. (2002a). Predictors of the risk of mortality in neurofibromatosis 2. American Journal of Human Genetics, 71, 715–723. 4. Baser, M. E., Friedman, J. M., Wallace, A. J., et al. (2002b). Evaluation of clinical diagnostic criteria for neurofibromatosis 2. Neurology, 59, 1759–1765. 5. Baser, M. E., Friedman, J. M., Joe, H., et al. (2011). Empirical development of improved diagnostic for neurofibromatosis 2. Genetics in Medicine, 13, 576–581.
|
|